started · updated
Hepatitis D identified as highly aggressive liver infection
Hepatitis D, also known as Delta-hepatitis, is characterized as one of the most aggressive forms of chronic liver inflammation. The infection is caused by the Hepatitis D virus (HDV), a small RNA virus that requires the Hepatitis B virus to complete its life cycle by using its outer shell. Consequently, Hepatitis D can only occur in individuals already infected with Hepatitis B.
While simultaneous infection with both viruses often results in recovery, a superinfection in individuals with chronic Hepatitis B carries a significantly higher risk of becoming a chronic condition. This can lead to severe complications, including liver cirrhosis, liver failure, liver cancer, or the necessity of a liver transplant.
Although treatment options were historically limited, the specific therapy Bulevirtid is now available in clinical practice. Other therapies are currently under development, but prevention remains a critical priority, with the Hepatitis B vaccine providing protection against the Delta variant.